These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 29067679

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The impact of Bakri balloon tamponade on the rate of postpartum hysterectomy for uterine atony.
    Lo A, St Marie P, Yadav P, Belisle E, Markenson G.
    J Matern Fetal Neonatal Med; 2017 May; 30(10):1163-1166. PubMed ID: 27364858
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic misoprostol for the prevention of postpartum hemorrhage: a randomized controlled trial.
    Uncu Y, Karahasan M, Uyaniklar Ö, Uncu G.
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):15-22. PubMed ID: 25635970
    [Abstract] [Full Text] [Related]

  • 4. The Bakri tamponade balloon as an adjunct treatment for refractory postpartum hemorrhage.
    Brown H, Okeyo S, Mabeya H, Wilkinson J, Schmitt J.
    Int J Gynaecol Obstet; 2016 Dec; 135(3):276-280. PubMed ID: 27612530
    [Abstract] [Full Text] [Related]

  • 5. Predictors of severity in primary postpartum hemorrhage.
    Ekin A, Gezer C, Solmaz U, Taner CE, Dogan A, Ozeren M.
    Arch Gynecol Obstet; 2015 Dec; 292(6):1247-54. PubMed ID: 26041324
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.
    Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.
    Int J Gynaecol Obstet; 2016 Sep; 134(3):324-8. PubMed ID: 27350226
    [Abstract] [Full Text] [Related]

  • 7. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.
    Leduc D, Senikas V, Lalonde AB, CLINICAL PRACTICE OBSTETRICS COMMITTEE.
    J Obstet Gynaecol Can; 2009 Oct; 31(10):980-993. PubMed ID: 19941729
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PRIMARY POSTPARTUM HAEMORRHAGE IN FEDERAL MEDICAL CENTRE, OWERRI, NIGERIA: A SIX YEAR REVIEW.
    Onyema OA, Cornelius AC, Uchenna ET, Duke OA.
    Niger J Med; 2015 Oct; 24(3):242-5. PubMed ID: 27487595
    [Abstract] [Full Text] [Related]

  • 10. Emergency obstetric hysterectomy for life-threatening postpartum hemorrhage: A 12-year review.
    Zhang Y, Yan J, Han Q, Yang T, Cai L, Fu Y, Cai X, Guo M.
    Medicine (Baltimore); 2017 Nov; 96(45):e8443. PubMed ID: 29137030
    [Abstract] [Full Text] [Related]

  • 11. Uterine atony.
    Miller HE, Ansari JR.
    Curr Opin Obstet Gynecol; 2022 Apr 01; 34(2):82-89. PubMed ID: 35102109
    [Abstract] [Full Text] [Related]

  • 12. Analysis of 59 cases of emergent peripartum hysterectomies during a 13-year period.
    Ozden S, Yildirim G, Basaran T, Gurbuz B, Dayicioglu V.
    Arch Gynecol Obstet; 2005 Apr 01; 271(4):363-7. PubMed ID: 15205986
    [Abstract] [Full Text] [Related]

  • 13. A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt.
    Anger HA, Dabash R, Hassanein N, Darwish E, Ramadan MC, Nawar M, Charles D, Breebaart M, Winikoff B.
    BMC Pregnancy Childbirth; 2020 May 24; 20(1):317. PubMed ID: 32448257
    [Abstract] [Full Text] [Related]

  • 14. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
    Chaudhuri P, Mandi S, Mazumdar A.
    J Obstet Gynaecol Res; 2014 Sep 24; 40(9):2023-30. PubMed ID: 25181622
    [Abstract] [Full Text] [Related]

  • 15. Randomized double-blind placebo-controlled trial of buccal misoprostol to reduce the need for additional uterotonic drugs during cesarean delivery.
    Hernández-Castro F, López-Serna N, Treviño-Salinas EM, Soria-López JA, Sordia-Hernández LH, Cárdenas-Estrada E.
    Int J Gynaecol Obstet; 2016 Feb 24; 132(2):184-7. PubMed ID: 26534874
    [Abstract] [Full Text] [Related]

  • 16. Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial.
    Quibel T, Ghout I, Goffinet F, Salomon LJ, Fort J, Javoise S, Bussieres L, Aegerter P, Rozenberg P, Groupe de Recherche en Obstétrique et Gynécologie (GROG).
    Obstet Gynecol; 2016 Oct 24; 128(4):805-11. PubMed ID: 27607864
    [Abstract] [Full Text] [Related]

  • 17. Emergency peripartum hysterectomy: a comparison of cesarean and postpartum hysterectomy.
    Forna F, Miles AM, Jamieson DJ.
    Am J Obstet Gynecol; 2004 May 24; 190(5):1440-4. PubMed ID: 15167863
    [Abstract] [Full Text] [Related]

  • 18. Second-line uterotonics and the risk of hemorrhage-related morbidity.
    Butwick AJ, Carvalho B, Blumenfeld YJ, El-Sayed YY, Nelson LM, Bateman BT.
    Am J Obstet Gynecol; 2015 May 24; 212(5):642.e1-7. PubMed ID: 25582104
    [Abstract] [Full Text] [Related]

  • 19. Carbetocin in prevention of postpartum hemorrhage: Experience in a tertiary medical center of Taiwan.
    Chen CY, Su YN, Lin TH, Chang Y, Horng HC, Wang PH, Yeh CC, Chang WH, Huang HY.
    Taiwan J Obstet Gynecol; 2016 Dec 24; 55(6):804-809. PubMed ID: 28040124
    [Abstract] [Full Text] [Related]

  • 20. Emergency Peripartum Hysterectomy as Postpartum Hemorrhage Treatment: Incidence, Risk factors, and Complications.
    Pradhan M, Shao Y.
    JNMA J Nepal Med Assoc; 2014 Dec 24; 52(193):668-76. PubMed ID: 26905546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.